These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21822026)

  • 61. Vitamin D Intake and its Protective Role in Multiple Sclerosis: The Checkmate to Survivin?
    Mormile R
    Iran J Pharm Res; 2016; 15(2):383-4. PubMed ID: 27642308
    [No Abstract]   [Full Text] [Related]  

  • 62. Correction for Ostkamp et al., Sunlight exposure exerts immunomodulatory effects to reduce multiple sclerosis severity.
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34253619
    [No Abstract]   [Full Text] [Related]  

  • 63. Complementary and alternative medicine in multiple sclerosis.
    Bowling AC
    Continuum (Minneap Minn); 2010 Oct; 16(5 Multiple Sclerosis):78-89. PubMed ID: 22810599
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Association between sun exposure habits and disease progression in multiple sclerosis.
    Wu J; Olsson T; Alfredsson L; Hedström AK
    Eur J Neurol; 2024 Jun; 31(6):e16269. PubMed ID: 38440929
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A combination of Q-TOF LC/MS and LC-MS/MS based metabolomics in pediatric-onset multiple sclerosis demonstrates potential biomarkers for unclassified patients.
    Solmaz İ; Kaplan O; Çelebier M; Lay İ; Anlar B
    Turk J Med Sci; 2022 Aug; 52(4):1299-1310. PubMed ID: 36326407
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.
    Maglione A; Zuccalà M; Tosi M; Clerico M; Rolla S
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440354
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Consensus statement from 2
    Giustina A; Adler RA; Binkley N; Bollerslev J; Bouillon R; Dawson-Hughes B; Ebeling PR; Feldman D; Formenti AM; Lazaretti-Castro M; Marcocci C; Rizzoli R; Sempos CT; Bilezikian JP
    Rev Endocr Metab Disord; 2020 Mar; 21(1):89-116. PubMed ID: 32180081
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.
    Maglione A; Rolla S; Mercanti SF; Cutrupi S; Clerico M
    Cells; 2019 Oct; 8(10):. PubMed ID: 31635066
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effectiveness of Vitamin D Supplementation in the Management of Multiple Sclerosis: A Systematic Review.
    Berezowska M; Coe S; Dawes H
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30875858
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Role of Invariant NKT in Autoimmune Liver Disease: Can Vitamin D Act as an Immunomodulator?
    Smyk DS; Mavropoulos A; Mieli-Vergani G; Vergani D; Lenzi M; Bogdanos DP
    Can J Gastroenterol Hepatol; 2018; 2018():8197937. PubMed ID: 30046564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.
    Koduah P; Paul F; Dörr JM
    EPMA J; 2017 Dec; 8(4):313-325. PubMed ID: 29209434
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
    Dörr J; Döring A; Paul F
    EPMA J; 2013 Jan; 4(1):4. PubMed ID: 23356351
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A Randomised, Double-Blind, Placebo-Controlled Trial with Vitamin D3 in MS: Subgroup Analysis of Patients with Baseline Disease Activity Despite Interferon Treatment.
    Aivo J; Lindsröm BM; Soilu-Hänninen M
    Mult Scler Int; 2012; 2012():802796. PubMed ID: 22919492
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB; Haentjens P; Nagels G; Garmyn M; De Keyser J
    Mult Scler; 2012 Apr; 18(4):451-9. PubMed ID: 21952096
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sun exposure, vitamin D and age at disease onset in relapsing multiple sclerosis.
    McDowell TY; Amr S; Culpepper WJ; Langenberg P; Royal W; Bever C; Bradham DD
    Neuroepidemiology; 2011; 36(1):39-45. PubMed ID: 21160231
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Sun exposure and vitamin D are independent risk factors for CNS demyelination.
    Lucas RM; Ponsonby AL; Dear K; Valery PC; Pender MP; Taylor BV; Kilpatrick TJ; Dwyer T; Coulthard A; Chapman C; van der Mei I; Williams D; McMichael AJ
    Neurology; 2011 Feb; 76(6):540-8. PubMed ID: 21300969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Modifiable factors influencing relapses and disability in multiple sclerosis.
    D'hooghe MB; Nagels G; Bissay V; De Keyser J
    Mult Scler; 2010 Jul; 16(7):773-85. PubMed ID: 20483884
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Multiple sclerosis and vitamin D: an update.
    VanAmerongen BM; Dijkstra CD; Lips P; Polman CH
    Eur J Clin Nutr; 2004 Aug; 58(8):1095-109. PubMed ID: 15054436
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.
    McDowell TY; Amr S; Culpepper WJ; Langenberg P; Royal W; Bever C; Bradham DD
    Neuroepidemiology; 2011; 37(1):52-7. PubMed ID: 21822026
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.